The rapid advancement of nanotechnology has outpaced the development of regulatory frameworks. Traditional regulations may not adequately address the unique properties and behaviors of nanomaterials. For instance, standard toxicity testing methods may not be suitable for assessing the risks of nanoparticles. This creates a need for updated guidelines and risk assessment protocols specifically tailored to nanomaterials.
